Revvity (RVTY) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Core Insights - Wall Street analysts forecast Revvity (RVTY) will report quarterly earnings of $1.14 per share, reflecting a year-over-year decline of 10.9% [1] - Anticipated revenues are projected to be $699.98 million, showing a 2.3% increase compared to the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised upward by 0.2% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions to the stock [3] Revenue Projections - Analysts estimate 'Net Sales- Life Sciences' will reach $338.39 million, representing a year-over-year increase of 12.5% [5] - 'Net Sales- Diagnostics' is expected to be $361.25 million, indicating a decline of 5.8% from the previous year [5] - 'Organic revenue growth - Diagnostics' is forecasted at 0.2%, down from 5.0% a year ago [5] Stock Performance - Revvity shares have increased by 13% over the past month, outperforming the Zacks S&P 500 composite, which rose by 1.1% [5] - With a Zacks Rank of 4 (Sell), RVTY is expected to underperform the overall market in the near term [5]